News

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

CBS News Nov 9, 2026 · 6:44 PM 0 views 0 comments

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces — Image: CBS News

The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.

CBS News Original story · www.cbsnews.com

Read the full story

How does this story make you feel?

👍 ❤️ 💡 😮 😂 😢 😠

Discussion (0)

No comments yet. Start the conversation!

CBS News + Follow

Section: News + Follow

Up next from CBS News

Ohio State frat suspended after video shows 2 students with sweatpants on fire

Warning: Disturbing video. Ohio State put Sigma Alpha Epsilon on an immediate, temporary suspension "pending a full investigation" after an off-campus video showed two…

CBS News 2 hours ago

FDA orders class-wide GLP-1 label update to include risk for rare eye disease

Hacker News (Newest) 1 hour ago

News

FDA warns of rare vision-loss side effect from GLP-1 drugs

CBS News 2 hours ago

Texas

FDA adds rare vision-loss warning to popular GLP-1 drugs

KSAT San Antonio 6 hours ago

Discussion (0)

More to read

FDA adds rare vision-loss warning to popular GLP-1 drugs

FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s

FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness